Intratumoral Hypoxia Reduces IFN-γ–Mediated Immunity and MHC Class I Induction in a Preclinical Tumor Model

por Murthy, Aditi, Gerber, Scott A., Koch, Cameron J., Lord, Edith M.
Publicado 2019

Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model

por Lim, Joanne YH, Brockstedt, Dirk G, Lord, Edith M, Gerber, Scott A
Publicado 2014

Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity

por Ortiz-Bonilla, Carlos J., Uccello, Taylor P., Gerber, Scott A., Lord, Edith M., Messing, Edward M., Lee, Yi-Fen
Publicado 2022

Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes

por Connolly, Kelli A., Belt, Brian A., Figueroa, Nathania M., Murthy, Aditi, Patel, Ankit, Kim, Minsoo, Lord, Edith M., Linehan, David C., Gerber, Scott A.
Publicado 2016

Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model

por Qin, Shuyang S., Han, Booyeon J., Williams, Alyssa, Jackson, Katherine M., Jewell, Rachel, Chacon, Alexander C., Lord, Edith M., Linehan, David C., Kim, Minsoo, Reuben, Alexandre, Gerber, Scott A., Prieto, Peter A.
Publicado 2021

CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models

por Ye, Jian, Gavras, Nicholas W, Keeley, David C, Hughson, Angela L, Hannon, Gary, Vrooman, Tara G, Lesch, Maggie L, Johnston, Carl J, Lord, Edith M, Belt, Brian A, Linehan, David C, Eyles, Jim, Gerber, Scott A
Publicado 2023

Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

por Ye, Jian, Mills, Bradley N, Qin, Shuyang S, Garrett-Larsen, Jesse, Murphy, Joseph D, Uccello, Taylor P, Han, Booyeon J, Vrooman, Tara G, Johnston, Carl J, Lord, Edith M, Belt, Brian A, Linehan, David C, Gerber, Scott A
Publicado 2022

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy

por Gerber, Scott, Uccello, Taylor, Lesch, Maggie, Kintzel, Sarah, Gradzewicz, Lauren, Lamrous, Lillia, Murphy, Shawn, Fleming, Fergal, Mills, Bradley, Murphy, Joseph, Hughson, Angela, Garrett-Larsen, Jesse, Qiu, Haoming, Drage, Michael, Ye, Jian, Gavras, Nicholas, Keeley, David, Love, Tanzy, Repasky, Elizabeth, Lord, Edith, Linehan, David
Publicado 2023

Development of an Orthotopic Murine Model of Rectal Cancer in Conjunction With Targeted Short-Course Radiation Therapy

por Uccello, Taylor P., Kintzel, Sarah A., Mills, Bradley N., Murphy, Joseph D., Garrett-Larsen, Jesse, Battaglia, Nicholas G., Rodriguez, Carlos J., Drage, Michael G., Ye, Jian, Love, Tanzy M.T., Johnston, Carl J., Repasky, Elizabeth A., Qiu, Haoming, Linehan, David C., Lord, Edith M., Gerber, Scott A.
Publicado 2021

Stereotactic Body Radiation and Interleukin-12 Combination Therapy Eradicates Pancreatic Tumors by Repolarizing the Immune Microenvironment

por Mills, Bradley N., Connolly, Kelli A., Ye, Jian, Murphy, Joseph D., Uccello, Taylor P., Han, Booyeon J., Zhao, Tony, Drage, Michael G., Murthy, Aditi, Qiu, Haoming, Patel, Ankit, Figueroa, Nathania M., Johnston, Carl J., Prieto, Peter A., Egilmez, Nejat K., Belt, Brian A., Lord, Edith M., Linehan, David C., Gerber, Scott A.
Publicado 2019

New insights into the responder/nonresponder divide in rectal cancer: Damage-induced Type I IFNs dictate treatment efficacy and can be targeted to enhance radiotherapy

por Uccello, Taylor P., Lesch, Maggie L., Kintzel, Sarah A., Gradzewicz, Lauren B., Lamrous, Lillia, Murphy, Shawn P., Fleming, Fergal J., Mills, Bradley N., Murphy, Joseph D., Hughson, Angela, Hannon, Gary, Garrett-Larsen, Jesse, Qiu, Haoming, Drage, Michael G., Ye, Jian, Gavras, Nicholas W., Keeley, David C., Love, Tanzy M. T., Repasky, Elizabeth A., Lord, Edith M., Linehan, David C., Gerber, Scott A.
Publicado 2023